Company expects to have sufficient cash to fund planned operations beyond the FDA PDUFA goal date and anticipated fourth ...

Appointment adds significant clinical and scientific expertise in the field of psychedelic-based therapies New York, New York--(Newsfile Corp. - March 18, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ...